Table 9.
Treatment groups | LDH (U/L) | Troponin I (ng/ml) |
---|---|---|
I | 4204 ± 637.1a+ | 21.18 ± 7.72c+ |
II | 3734 ± 251.5 | 3.29 ± 2.41f– |
III | 2781 ± 657.5d– | 7.93 ± 7.03d– |
IV | 2939 ± 184.1d– | 10.63 ± 6.7d– |
V | 2530 ± 189.2d– | 2.96 ± 1.71f– |
VI | 2214 ± 340.1d– | 3.53 ± 1.84f– |
VII | 2907 ± 204.4d– | 3.46 ± 1.71f– |
VIII | 3331 ± 227.5 | 4.11 ± 2.59 |
a+, c+Significant increases at p < 0.05 and p < 0.0001, respectively, when compared to the untreated negative (normal) control values. d−,f−Significant decreases at p < 0.05 and p < 0.0001, respectively, when compared to the untreated positive (doxorubicin treated only) control values, respectively.